IPF Summit 2026

Vitalograph is proud to be a sponsor and exhibitor at the 11th IPF Summit, bringing together industry leaders, researchers, clinicians, and drug developers dedicated to advancing treatments for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.

As the IPF landscape continues to evolve, this year's summit will explore key topics impacting pulmonary fibrosis drug development, including novel therapeutic targets, translational science, biomarker innovation, patient-centered care, clinical trial optimization, combination therapies, and the changing investment environment shaping future research.

Featured Vitalograph Presentation

Wednesday | 3:30 PM

Be sure to join Vitalograph's sesssion on Wednesday at 3:00 PM, where Director of Cough Solutions, Laura Kütt, will explore objective cough frequency monitoring as a meaningful endpoint in IPF clinical trials.

Why Cough Counts: Cough as an Endpoint in Pulmonary Fibrosis Research

Laura Kütt | Director of Cough Solutions, Vitalograph

• Exploring how cough is measured in clinical research and trials, including objective and subjective methods and the relationship between them

• Reviewing case studies using objective cough measurement as an endpoint in IPF and cystic fibrosis research

• Discussing latest advancements in automated cough monitoring that make cough research more feasible across respiratory diseases